Seaport Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2024 | — | $-24.8M | — |
| Mar 2025 | — | $-36.2M | — |
| Jun 2025 | — | $-49.5M | — |
| Dec 2025 | — | $-92.5M | $46.0M |
| Mar 2026 | — | $-115.6M | $52.9M |
| Jun 2026 | — | $422.6M | $64.2M |
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2024 | — | $-24.8M | — |
| Mar 2025 | — | $-36.2M | — |
| Jun 2025 | — | $-49.5M | — |
| Dec 2025 | — | $-92.5M | $46.0M |
| Mar 2026 | — | $-115.6M | $52.9M |
| Jun 2026 | — | $422.6M | $64.2M |